Jessica Garlewicz, Digital Managing Editor

psoriasis
News
Cardiovascular Risk Assessment in Psoriasis
06/20/2024
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate...
06/20/2024
Dermatology
psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
psoriatic arthritis
News
Readmissions After Hospitalization for Psoriatic Arthritis
06/20/2024
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
Researchers aimed to assess the rates, characteristics, and predictors of 30-day readmissions among adults hospitalized for psoriatic arthritis across the United States.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
Atopic dermatitis
News
Lebrikizumab for Moderate to Severe Atopic Dermatitis in Patients Age ≥60 Years
06/20/2024
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD) significantly impacts adults, with a meta-analysis showing that 26.1% of AD cases have an onset after age 16 years.
Atopic dermatitis (AD)...
06/20/2024
The Dermatologist
AD
News
Ruxolitinib Cream for Patients With Facial and/or Neck Atopic Dermatitis
06/19/2024
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, a study evaluated the efficacy and safety of 1.5% ruxolitinib cream in treating AD in face/neck.
In a presentation showcased at...
06/19/2024
The Dermatologist
vitiligo
News
Vitiligo Biomarker CXCL10 Correlation With Clinical Response
06/18/2024
During the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, presenters showcased how ruxolitinib cream, a topical Janus kinase 1/JAK2 inhibitor, is the first US Food and Drug Administration and European Commission-approved...
During the Revolutionizing Atopic Dermatitis (RAD) June 2024 meeting, presenters showcased how ruxolitinib cream, a topical Janus kinase 1/JAK2 inhibitor, is the first US Food and Drug Administration and European Commission-approved...
During the Revolutionizing...
06/18/2024
The Dermatologist
SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
psoriatic arthritis
News
Anti-Inflammatory Diet and Fecal Microbiota Transplant in Psoriatic Arthritis
06/13/2024
Researchers aimed to explore the roles of anti-inflammatory diets and fecal microbiota transplant in PsA management.
Researchers aimed to explore the roles of anti-inflammatory diets and fecal microbiota transplant in PsA management.
Researchers aimed to explore the...
06/13/2024
The Dermatologist
psoriasis
News
Shared Biomarkers and Pathways in Psoriasis and Cervical Squamous Cell Carcinoma
06/13/2024
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the...
06/13/2024
The Dermatologist
psoriasis
News
Nail Psoriasis Association With IL-17
06/07/2024
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate...
06/07/2024
Dermatology

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use